Acquisitions Purchase
Biotechnology Acquisitions in 2024
Review the export, choose years, and enter your email to continue.
Full Export
Purchase the full list for Biotechnology Acquisitions in 2024
90 rows · from $90 · CSV + XLSX
Show details
Hide details
Full Export
Purchase the full list for Biotechnology Acquisitions in 2024
90 rows · from $90 · CSV + XLSX
Get a point-in-time export of all tracked rows for this page. We email the file immediately after purchase.
What the export looks like
| Date | Title | Buyers | Targets | Industry | Transaction Type | Location | Closing Status |
|---|---|---|---|---|---|---|---|
| 2024-12-24 | Altaris Acquires WuXi AppTec's Advanced Therapies U.S. and U.K. Operations (including OXGENE) | Altaris, LLC | Advanced Therapies (U.S. and U.K. operations of WuXi AppTec's Advanced Therapies Unit); OXGENE | Biotechnology | Addon | Pennsylvania, United States | Confirmed closed |
| 2024-12-12 | Tenpoint Therapeutics and Visus Therapeutics Complete Merger to Advance Ophthalmic Pipeline | Tenpoint Therapeutics Limited | Visus Therapeutics, Inc. | Biotechnology | Buyout | Washington, United States | Confirmed closed |
| 2024-12-11 | AbbVie Completes $1.4B Acquisition of Aliada Therapeutics | AbbVie | Aliada Therapeutics | Biotechnology | Buyout | United States | Confirmed closed |
Each purchase includes both CSV and XLSX files, emailed to you immediately.